Gyeonghwa Kim

9PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Molecular targetsHaematologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 17, 2026
Targeting EHMT2 overcomes 5-fluorouracil resistance in colorectal cancer by modulating cell cycle and apoptosis.

|May 11, 2024
MicroRNA-135b-5p Is a Pathologic Biomarker in the Endothelial Cells of Arteriovenous Malformations.

Joon Seok Lee, Gyeonghwa Kim, Jong Ho Lee

|Dec 21, 2023
GCSB-5 regulates inflammatory arthritis and pain by modulating the mitogen-activated protein kinase signaling pathway in a murine model of rheumatoid arthritis.

Jihye Bang, Gyeonghwa Kim, Soo Young Park

|Oct 28, 2023
Tissue Circular RNA_0004018 and 0003570 as Novel Prognostic Biomarkers for Hepatitis B-Related Hepatocellular Carcinoma.

Min-Kyu Kang, Gyeonghwa Kim, Jung Gil Park

|Sep 24, 2022
Inhibition of USP1 enhances anticancer drugs-induced cancer cell death through downregulation of survivin and miR-216a-5p-mediated upregulation of DR5.

Seon Min Woo, Seok Kim, Seung Un Seo

|Aug 26, 2022
Circular Noncoding RNA hsa_circ_0003570 as a Prognostic Biomarker for Hepatocellular Carcinoma.

Se Young Jang, Gyeonghwa Kim, Won Young Tak

Pageof 2

Frequent Collaborators

6 joint publications

Keun Hur

5 joint publications

Soo-Young Park

4 joint publications

Se-Young Jang

4 joint publications

Yu-Rim Lee